Day One Biopharmaceuticals, Inc. (DAWN) Financials

NASDAQ Currency in USD Disclaimer

$12.67

south_east -$0.02 (-0.16%)
Day's range
$12.43
Day's range
$12.79

DAWN Income statement / Annual

Last year (2023), Day One Biopharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Day One Biopharmaceuticals, Inc.'s net income was -$188.92 M. See Day One Biopharmaceuticals, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $383,000.00 $531,000.00 $199,000.00 $155,000.00 $0.00
Gross Profit -$383,000.00 -$531,000.00 -$199,000.00 -$155,000.00 $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $130.52 M $85.62 M $43.58 M $9.10 M $13.90 M
General & Administrative Expenses $75.54 M $61.29 M $29.16 M $4.68 M $1.01 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $75.54 M $61.29 M $29.16 M $4.68 M $1.01 M
Other Expenses $1.00 -$18,000.00 -$15,000.00 -$31,000.00 -$2,000.00
Operating Expenses $206.06 M $146.91 M $72.74 M $13.78 M $14.91 M
Cost And Expenses $206.06 M $146.91 M $72.74 M $13.78 M $14.91 M
Interest Income $17.19 M $4.75 M $4,000.00 $30.00 $2,077.00
Interest Expense $0.00 $4.75 M $4,000.00 $30,000.00 $2.08 M
Depreciation & Amortization $383,000.00 $531,000.00 $199,000.00 $155,000.00 $14.91 M
EBITDA -$206.06 M -$141.65 M -$72.56 M -$43.66 M -$2,000.00
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $17.15 M $4.73 M -$11,000.00 -$30.06 M -$2.08 M
Income Before Tax -$188.92 M -$142.18 M -$72.75 M -$43.84 M -$16.98 M
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $0.00 -$10.01 M -$2.31 M -$3.34 M -$2.27 M
Net Income -$188.92 M -$132.18 M -$70.44 M -$40.51 M -$14.71 M
Net Income Ratio 0 0 0 0 0
EPS -2.37 -2.02 -1.14 -0.65 -0.24
EPS Diluted -2.37 -2.02 -1.14 -0.65 -0.24
Weighted Average Shares Out $79.77 M $65.47 M $61.95 M $61.93 M $61.93 M
Weighted Average Shares Out Diluted $79.77 M $65.47 M $61.95 M $61.93 M $61.93 M
Link